RxDoctor Payments Data

George Coleman, MD

Family Medicine · Waverly, VANPI 1053390906

Payments from drug & device makers

$903in general payments, 2019–2025

Across 59 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$231
  • AbbVie$153
  • Lilly USA, LLC$131
  • Pfizer$106
  • Novartis$86
  • AstraZeneca$74
  • plus $121 from 4 others

What the payments were for

  • Food & beverage$84894%
  • Education$566%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$903 in reported general payments places this provider in the 65th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$2,940
Medicare patients
135
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$85,824
EliquisApixaban88$72,613
JardianceEmpagliflozin76$69,395
TrulicityDulaglutide53$68,825
XareltoRivaroxaban56$49,067
FarxigaDapagliflozin Propanediol31$25,031
TradjentaLinagliptin19$18,091
EntrestoSacubitril/Valsartan12$16,232
Tresiba Flextouch U-100Insulin Degludec32$15,319
LinzessLinaclotide25$14,433
MyrbetriqMirabegron30$14,066
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$11,284
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$10,206
SymbicortBudesonide/Formoterol Fumarate33$8,509
DuleraMometasone/Formoterol15$7,308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$14$87,48695 claims
Novo NordiskOzempic$231$85,82460 claims
PfizerEliquis$106$72,61388 claims
Lilly USA, LLCTrulicity$131$68,82553 claims
Johnson & JohnsonXarelto$55$49,06756 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$74$44,82480 claims
NovartisEntresto$86$16,23212 claims
AbbVieLinzess$153$14,43325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Waverly

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →